Reference
Makimoto G, et al. Successful Treatment with Lorlatinib after the Development of Alectinib-Induced Liver Damage in ALK-Positive Non-Small-Cell Lung Cancer: A Case Report. Case Reports in Oncology 14: 197-201, No. 1, Jan 2021. Available from: URL: http://content.karger.com/ProdukteDB/produkte.asp?Aktion=BackIssuesJG&searchParm=2010&ProduktNr=239061
Rights and permissions
About this article
Cite this article
Alectinib. Reactions Weekly 1860, 28 (2021). https://doi.org/10.1007/s40278-021-97483-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-97483-1